586 related articles for article (PubMed ID: 6392723)
1. Immunopathology of non-Hodgkin lymphomas.
Huber H; Gattringer C; Knapp W; Stein H
Klin Wochenschr; 1984 Nov; 62(21):1001-10. PubMed ID: 6392723
[TBL] [Abstract][Full Text] [Related]
2. [Immunocytologic diagnosis of leukemia and lymphoma: monoclonal antibodies in the differential diagnosis of hematologic neoplasms].
Huber H; Gattringer C; Thaler J; Peschel C
Behring Inst Mitt; 1985 Dec; (78):83-117. PubMed ID: 3914283
[TBL] [Abstract][Full Text] [Related]
3. [Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)].
Stein H
Immun Infekt; 1976 Apr; 4(2):52-69. PubMed ID: 1085745
[TBL] [Abstract][Full Text] [Related]
4. [Studies of immunologic markers in malignant lymphomas: diagnostic and prognostic relevance].
Huber H; Thaler J; Greil R; Gattringer C; Radaszkiewicz T
Onkologie; 1986 Apr; 9(2):108-13. PubMed ID: 3520418
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
6. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
[TBL] [Abstract][Full Text] [Related]
7. Non-Hodgkin's lymphoma phenotyping: problems in the use of heterologous and monoclonal antibodies.
Barcos M; Minowada J; Minato K; Pollard C; Cancino M; Han T; Henderson E; Ozer H
Leuk Res; 1983; 7(4):523-37. PubMed ID: 6604849
[TBL] [Abstract][Full Text] [Related]
8. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
[TBL] [Abstract][Full Text] [Related]
9. Infiltration density of HNK 1 positive cells in non-Hodgkin's lymphomas depends on histologic subtype: an in situ morphometric analysis.
Gattringer C; Radaszkiewicz T; Pfaller W; Huber H
Immunobiology; 1985 Apr; 169(3):280-91. PubMed ID: 3997199
[TBL] [Abstract][Full Text] [Related]
10. Correlation between histology and immunophenotype in a series of 322 cases of non-Hodgkin's lymphoma.
Smith JL; Jones DB; Bell AJ; Wright DH
Hematol Oncol; 1989; 7(1):37-48. PubMed ID: 2642457
[TBL] [Abstract][Full Text] [Related]
11. Imbalance of helper and suppressor T lymphocytes in malignant non-Hodgkin lymphomas: an in situ morphometric analysis.
Gattringer C; Huber H; Radaszkiewicz T; Pfaller W; Braunsteiner H
Int J Cancer; 1984 Jun; 33(6):751-7. PubMed ID: 6234239
[TBL] [Abstract][Full Text] [Related]
12. [Non-Hodgkin's lymphoma. Cytology and cytochemistry].
Schwarze EW
Veroff Pathol; 1986; 123():1-241. PubMed ID: 3518274
[TBL] [Abstract][Full Text] [Related]
13. Cell-surface-marker phenotyping in patients with leukemic non-Hodgkin lymphomas (NHL) of low and intermediate malignancy.
Herrmann F; Wirthmüller R
Immunobiology; 1982 Oct; 163(1):77-94. PubMed ID: 7173978
[TBL] [Abstract][Full Text] [Related]
14. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G
Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
[TBL] [Abstract][Full Text] [Related]
15. Immunologic classification of lymphocytic leukemias based on monoclonal antibody-defined cell surface antigens.
Schroff RW; Foon KA; Billing RJ; Fahey JL
Blood; 1982 Feb; 59(2):207-15. PubMed ID: 7034809
[TBL] [Abstract][Full Text] [Related]
16. Lymphoid leukemia and non-Hodgkin's lymphoma type continuum, superimposed to lymphocyte differentiation step continuum. A proposition for a revised W. H. O. lympiioid leukemia-lymphoma categorisation.
Mathé G
Biomed Pharmacother; 1985; 39(3):109-14. PubMed ID: 3864494
[TBL] [Abstract][Full Text] [Related]
17. [Immunopathology of lymphatic systemic diseases].
Huber H; Gattringer C
Wien Klin Wochenschr; 1983 May; 95(10):319-26. PubMed ID: 6351444
[TBL] [Abstract][Full Text] [Related]
18. Expression of the T1 (CD5, p67) surface antigen in B-CLL and B-NHL and its correlation with other B-cell differentiation markers.
Delia D; Bonati A; Giardini R; Villa S; De Braud F; Cattoretti G; Rilke F
Hematol Oncol; 1986; 4(3):237-48. PubMed ID: 3095211
[TBL] [Abstract][Full Text] [Related]
19. [Immunoperoxidase study of normal and pathologic lymphoid tissue. Value of monoclonal antibodies].
Delsol G; Al Saati T; Caveriviere P; Voigt JJ; Ancelin E; Rigal-Huguet F
Ann Pathol; 1984; 4(3):165-83. PubMed ID: 6383412
[TBL] [Abstract][Full Text] [Related]
20. Characterization of malignant and non-neoplastic cell phenotypes in highly malignant non-Hodgkin lymphomas.
Porwit-Ksiazek A; Christensson B; Lindemalm C; Mellstedt H; Tribukait B; Biberfeld G; Biberfeld P
Int J Cancer; 1983 Dec; 32(6):667-74. PubMed ID: 6317576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
